Preparation and Antitumor Activity of Doxorubicin-Loaded Hyaluronic Acid Modified Liposomes
CSTR:
Author:
Affiliation:

Clc Number:

R944

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Doxorubicin(DOX)-loaded hyaluronic acid(HA) modified Liposomes(DOX/LP/ HOA) were prepared to enhance receptor mediated endocytosis and improve anti-tumor effect. Octadecyl was chosen to conjugate HA backbone by amide bond to prepare hyaluronic acid-octodecane(HOA) polymers. DOX,as a model drug,was encapsulated into HOA modified liposomes by the film dispersion method and post-insertion method. The average particle size,zeta potential and encapsulation of DOX/LP/HOA were(50.17±0.60) nm,(-7.61±0.43) mV and(98.85±0.40)%,respectively. In vitro release and cytotoxicity results showed that DOX/LP/HOA could release DOX slowly and improve tumor targeting ability. DOX/LP/HOA with excellent anti-tumor activity can be used as the potential carrier for delivery of anti-tumor drugs.

    Reference
    Related
    Cited by
Get Citation

HUANG Yan, QIU Lipeng, ZHU Mengqin, SU Dandan, CHEN Jinghua. Preparation and Antitumor Activity of Doxorubicin-Loaded Hyaluronic Acid Modified Liposomes[J]. Journal of Food Science and Biotechnology,2018,37(12):1272-1277.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: January 04,2019
  • Published:
Article QR Code

Copy Right:Editorial Board of Journal of Food Science and Biotechnology

Address:No. 1800, Lihu Avenue, Wuxi 214122, Jiangsu Province,China  PostCode:214122

Phone:0510-85913526  E-mail:xbbjb@jiangnan.edu.cn

Supported by:Beijing E-Tiller Technology Development Co., Ltd.

WeChat

Mobile website